Grey’s Anatomy” star Camilla Luddington has revealed her very real medical crisis. The actress, 41, revealed on Wednesday’s episode of her “Call It What It Is” podcast that after constantly ...

Minoxidil remains the gold standard for treating hair loss, but new research shows these ingredients have strong potential.

Researchers at the University of Bath have developed a new technology that—for many patients—could make injections a thing of ...

The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.

The US Food and Drug Administration (FDA) has granted approval for Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd, ...

Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.

Sands Capital, an investment management company, released its “Sands Capital Technology Innovators Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.